Disordered development of gut microbiome interferes with the establishment of the gut ecosystem during early childhood with atopic dermatitis

Gut Microbes. 2022 Jan-Dec;14(1):2068366. doi: 10.1080/19490976.2022.2068366.

Abstract

The gut microbiome influences the development of allergic diseases during early childhood. However, there is a lack of comprehensive understanding of microbiome-host crosstalk. Here, we analyzed the influence of gut microbiome dynamics in early childhood on atopic dermatitis (AD) and the potential interactions between host and microbiome that control this homeostasis. We analyzed the gut microbiome in 346 fecal samples (6-36 months; 112 non-AD, 110 mild AD, and 124 moderate to severe AD) from the Longitudinal Cohort for Childhood Origin of Asthma and Allergic Disease birth cohort. The microbiome-host interactions were analyzed in animal and in vitro cell assays. Although the gut microbiome maturated with age in both AD and non-AD groups, its development was disordered in the AD group. Disordered colonization of short-chain fatty acids (SCFA) producers along with age led to abnormal SCFA production and increased IgE levels. A butyrate deficiency and downregulation of GPR109A and PPAR-γ genes were detected in AD-induced mice. Insufficient butyrate decreases the oxygen consumption rate of host cells, which can release oxygen to the gut and perturb the gut microbiome. The disordered gut microbiome development could aggravate balanced microbiome-host interactions, including immune responses during early childhood with AD.

Keywords: Gut; atopic dermatitis; development; homeostasis; microbiome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Butyrates
  • Dermatitis, Atopic*
  • Fatty Acids, Volatile
  • Gastrointestinal Microbiome* / genetics
  • Humans
  • Mice
  • Microbiota*

Substances

  • Butyrates
  • Fatty Acids, Volatile

Grants and funding

This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Korean government (MSIT) [Ministry of Science and ICT, South Korea NRF-2017M3A9F3043837, NRF-2017M3A9F3043853, and NRF-2021M3A9I4023974]; the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health and Welfare [Ministry of Health and Welfare HP20C0082]; the Research Program funded by the Korea Centers for Disease Control and Prevention [2020E670200 and 2020E670201].